Delhi hospital reports 13 cases of COVID-19 triggered mucormycosis

By NewsDesk @ bactiman63

Officials at Sir Ganga Ram Hospital in Delhi, India, are reporting at least 13 cases of mucormycosis triggered by COVID-19, a serious but rare fungal infection, according to several local media reports.

Mucor sp./CDC

Times of India reports: “In the past 15 days, we have seen 13 cases of COVID-19 triggered mucormycosis. Five died. At least three patients suffered from sight and had to have their nose and jaw bone removed to prevent the spread of infection, said Dr. Manish Munjal, a senior ENT surgeon. “Usually, we see one or two cases of mucormycosis in a month,” he added.

In one case, a 32-year-old recovering from COVID-19 experienced a nagging obstruction of his nose on his left side, which quickly became swollen eyes within two days, after which he contacted doctors. The left side of his face had gone completely numb and he was taken to the emergency hospital in a partially disoriented and dull state, according to an Indian Express report.

“His tests revealed the presence of very high sugar and infection levels, but even more deadly, the presence of a rare killer fungus called Mucor, which was taken from the debris of the nose. An MRI revealed that the infection had already destroyed a significant portion of the sinuses, eye, upper jaw bone and left side muscles and had even passed to the brain, “said Dr Munjal.

Low immunity in people recovering from COVID-19, due to infection or medications, is considered to be the cause of these unique cases.

India: Plasmodium ovale malaria reported in Kerala, found in a soldier returning from Africa

Zygomycosis, or mucormycosis, is acute fungal infection from a number of kinds of molds.

Infections with these fungi typically cause disease which is rapidly progressive, destructive and associated with a high mortality rate of 50% or greater.

It is more prevalent in those with weakened immune systems or other debilitating diseases such as diabetes. These fungi have an affinity for blood vessels and cause thrombosis, heart attack and tissue necrosis.

It is not communicable from person to person.

India’s news source, News 18, reports that this has not only been seen in Delhi but in other cities: Ahmedabad and Bengaluru. In Ahmedabad, mucormycosis has been reported in five patients suffering from both coronavirus or they had recently recovered: two had died and two had lost their sight.

In Bengaluru, mucormycosis was reported in four COVID-19-related patients, in which two died.

Vaccines: The full-dose DTaP booster vaccine, Tetraxim, launched in India

To date, India has reported 9.9 million cases of COVID-19, including 143,000 deaths.